Total Payments
$492.82
2024 Payments
$183.43
Companies
10
Transactions
20
Medicare Patients
4,615
Medicare Billing
$195,497
Payment Breakdown by Category
Food & Beverage$475.38 (96.5%)
Education$17.44 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $475.38 | 19 | 96.5% |
| Education | $17.44 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $140.02 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $117.51 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.40 | 4 | $0 (2024) |
| PFIZER INC. | $31.20 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $29.80 | 1 | $0 (2024) |
| Lilly USA, LLC | $21.68 | 1 | $0 (2024) |
| Abbott Laboratories | $21.32 | 1 | $0 (2022) |
| Novo Nordisk Inc | $13.64 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.43 | 9 | GlaxoSmithKline, LLC. ($92.20) |
| 2023 | $160.76 | 3 | Boston Scientific Corporation ($140.02) |
| 2022 | $100.80 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($53.82) |
| 2021 | $47.83 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18.47) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: DIABETES | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: RESPIRATORY | ||||||
| 05/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: UROLOGY | ||||||
| 07/26/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $140.02 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 06/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: DIABETES | ||||||
| 07/18/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Heart Failure | ||||||
| 06/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: DIABETES | ||||||
| 04/06/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2021 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $17.44 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 05/25/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: VACCINE | ||||||
| 04/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 918 | 1,325 | $101,932 | $35,086 |
| 2022 | 26 | 980 | 1,367 | $111,779 | $38,558 |
| 2021 | 29 | 1,243 | 1,733 | $175,748 | $60,646 |
| 2020 | 31 | 1,474 | 2,058 | $182,416 | $61,208 |
Total Patients
4,615
Total Services
6,483
Medicare Billing
$195,497
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 221 | $58,431 | $16,248 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $17,313 | $7,222 | 41.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 13 | $5,466 | $1,769 | 32.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 62 | 102 | $2,732 | $1,338 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 62 | 106 | $2,239 | $1,097 | 49.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 70 | 125 | $2,143 | $1,050 | 49.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 63 | 63 | $2,377 | $992.25 | 41.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 81 | $1,573 | $771.12 | 49.0% |
| 83525 | Insulin measurement, total | Office | 2023 | 30 | 53 | $1,212 | $593.60 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 36 | $1,210 | $592.56 | 49.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 54 | 73 | $1,134 | $555.53 | 49.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 49 | 70 | $809.20 | $396.20 | 49.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 49 | 70 | $725.20 | $355.60 | 49.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 20 | 24 | $723.84 | $354.72 | 49.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 20 | 24 | $705.60 | $345.84 | 49.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 25 | 36 | $649.44 | $318.24 | 49.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 15 | 15 | $579.30 | $283.80 | 49.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 13 | $354.38 | $173.68 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 15 | $459.00 | $115.92 | 25.3% |
| 83550 | Iron binding capacity | Office | 2023 | 12 | 13 | $227.24 | $111.41 | 49.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 11 | 12 | $193.68 | $94.92 | 49.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 40 | $180.00 | $88.00 | 48.9% |
| 83540 | Iron level | Office | 2023 | 12 | 13 | $168.22 | $82.42 | 49.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 21 | 25 | $158.50 | $77.75 | 49.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 16 | 17 | $170.68 | $58.16 | 34.1% |
About Elena Aleman, ARNP FNP BC, LMHC
Elena Aleman, ARNP FNP BC, LMHC is a Professional healthcare provider based in North Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841410545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elena Aleman, ARNP FNP BC, LMHC has received a total of $492.82 in payments from pharmaceutical and medical device companies, with $183.43 received in 2024. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($475.38).
As a Medicare-enrolled provider, Aleman has provided services to 4,615 Medicare beneficiaries, totaling 6,483 services with total Medicare billing of $195,497. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Professional
- Other Specialties Family
- Location North Fort Myers, FL
- Active Since 04/26/2007
- Last Updated 08/11/2025
- Taxonomy Code 101YP2500X
- Entity Type Individual
- NPI Number 1841410545
Products in Payments
- TRELEGY ELLIPTA (Drug) $117.51
- JARDIANCE (Drug) $79.93
- XARELTO (Drug) $29.80
- MOUNJARO (Drug) $21.68
- CARDIOMEMS (Device) $21.32
- PRADAXA (Drug) $18.47
- MYFEMBREE (Drug) $17.44
- ELIQUIS (Drug) $13.76
- Rybelsus (Drug) $13.64
- GARDASIL 9 (Biological) $11.92
- GEMTESA (Drug) $7.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.